Diligence memo · auto-generated · as of July 3, 2026

ProNova Solutions, LLC

ProNova Solutions, LLC looks under-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

ProNova Solutions, LLC operates in Biotechnology, based in KNOXVILLE.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

ProNova Solutions, LLC has raised $40M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $30M on 2014-10-30.

Most recent recorded round closed around 2014-11-01.

Valuation (modeled)modeled

Provath models ProNova Solutions, LLC at approximately $107M (range $5.4M–$413M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.15× the median modeled value of Series B Biotechnology companies in 2013–2015 (77 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 12 months.

Last raise 11.7 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 11.1× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 79% of Biotechnology peers (4293 compared).

Modeled value ranks above 60% of those peers.

Closest niche peers: BioAtla,LLC, Scholar Rock LLC, Oligasis, LLC, Alector LLC, Gelesis Inc.

Peoplefiled

20 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.